SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950133-04-001338
Filing Date
2004-04-09
Accepted
2004-04-09 15:05:05
Documents
4
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO THE 10-K w96094e10vkza.htm 10-K/A 131808
3 EX-10.22 w96094exv10w22.htm EX-10.22 78998
4 EX-31.01 w96094exv31w01.htm EX-31.01 4277
5 EX-31.02 w96094exv31w02.htm EX-31.02 4285
  Complete submission text file 0000950133-04-001338.txt   221105
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23736 | Film No.: 04726986
SIC: 2834 Pharmaceutical Preparations